Novartis hands over the Life-Science-Park Rhine Valley to GETEC Switzerland, the platform of a leading European energy supplier and contracting specialist GETEC Group. They are the new owner and operator of the properties and infrastructure
Tags :Daniel Kuhn
CDR-Life, a Swiss biotechnology company pioneering a new and differentiated class of highly tumor-specific immune-oncology therapeutics, has completed its Series A financing raising USD 76 million. The round was led by Jeito Capital and RA Capital
The law firm advises Swissport International on its comprehensive restructuring with creditors and shareholders including a debt-for-equity swap and a new 500 m euros long-term debt facility
